publication venue for
- Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease.. 21:299-313. 2025
- Drug stewardship in chronic kidney disease to achieve effective and safe medication use. 20:386-401. 2024
- Clonal haematopoiesis, ageing and kidney disease. 20:161-174. 2024
- Sexual orientation and gender identity in organ and tissue donation and transplantation. 19:357-358. 2023
- COVID-19 vaccines and kidney disease. 17:291-293. 2021
- Plant-based diets to manage the risks and complications of chronic kidney disease. 16:525-542. 2020
- New treatment paradigms for ADPKD: moving towards precision medicine. 13:750-768. 2017
- Renal and cardiac assessment of living kidney donor candidates. 13:420-428. 2017
- Net benefit of ticagrelor in patients with chronic kidney disease. 12:10-11. 2016
- Long-term medical risks to the living kidney donor. 11:411-419. 2015
- Do electronic alerts for AKI improve outcomes?. 11:322-323. 2015
- Economic evaluation of dialysis therapies. 10:644-652. 2014
- Anticoagulants in atrial fibrillation patients with chronic kidney disease. 8:569-578. 2012
- Author's response to “Depth of inflammation in Crohn's disease”. 5:E3-E3. 2009
- Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia. 5:54-58. 2009
- Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn's disease. 4:693-697. 2008